missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Lipofectamine™ CRISPRMAX™ Cas9 Transfection Reagent

Lipofectamine CRISPRMAX Cas9 Transfection Reagent

1978.00 SEK - 4475.00 SEK


Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
15466014
View Documents
Invitrogen™
CMAX00008
75 rxn(s)
4475.00 SEK
0.75mL
View alternative products
Save Up to 
»
In stock, ready to ship: 1
Add to basket
 
15435884
View Documents
Invitrogen™
CMAX00003
25 rxn(s)
1978.00 SEK
25 reactions
View alternative products
Save Up to 
»
In stock, ready to ship: 6
Add to basket
 
Description

Description

Lipofectamine™ CRISPRMAX™ Cas9 Transfection Reagent is the first optimized lipid nanoparticle transfection reagent for CRISPR-Cas9 protein delivery, providing the cleavage efficiency of electroporation with the simplicity and scalability of a reagent. Lipofectamine CRISPRMAX transfection reagent is an ideal alternative to electroporation as it is gentler on cells and more cost effective overall.

Offers our superior GeneArt™ Platinum™ Cas9 Nuclease as well as other CRISPR-Cas9 proteins with a reagent that enables:

  • Demonstrated cleavage efficiency—tested in over 20 cell types including iPSC, mESC, N2A, CHO, A549, HCT116, HeLa, HEK293, and several others
  • Low cell toxicity—less cells needed to initiate your experiment
  • Cost savings—whether cost-per-reaction or initial investment
  • Easily scalability—an ideal delivery solution for high throughput experiments

    Achieve high transfection efficiency in novel genome editing applications
    Lipofectamine CRISPRMAX transfection reagent helps increase the likelihood of successful cleavage and recombination, especially when combined with our GeneArt Platinum Cas9 Nuclease. This ultimately maximizes the efficiency of performing genetic modifications, simplifying your workflow when compared to electroporation.

    Improve experimental outcomes using GeneArt Platinum Cas9 Nuclease
    Unlike CRISPR plasmid or Cas9 mRNA, using Cas9 protein provides superior cleavage efficiency in primary cells and stem cells. It helps eliminate the need for transcription or translation of the payload, minimizes the risk of genomic integration, and is cell cycle independent.
  • SDS

    For Research Use Only. Not for use in diagnostic procedures.